Title: Contribution to the Factors Involved in the Protective Effect of Ischemic Preconditioning
Abstract: Annals of the New York Academy of SciencesVolume 793, Issue 1 p. 43-53 Contribution to the Factors Involved in the Protective Effect of Ischemic Preconditioning The Role of Catecholamines and Protein Kinase Ca TANYA RAVINGEROVÁ, Corresponding Author TANYA RAVINGEROVÁ Institute for Heart Research Slovak Academy of Sciences Bratislava, Slovakiab Address for correspondence: Dr. T. Ravingerová, Institute for Heart Research, Slovak Academy of Sciences, Dubravska cesta 9, 842 33 Bratislava, Slovakia. Fax: 427 376 637.Search for more papers by this authorMIROSLAV BARANČÍK, MIROSLAV BARANČÍK Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorDEZIDER PANCZA, DEZIDER PANCZA Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorJÁN STYK, JÁN STYK Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorATTILA ZIEGELHÖFFER, ATTILA ZIEGELHÖFFER Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorWOLFGANG SCHAPER, WOLFGANG SCHAPER Institute for Heart Research Slovak Academy of Sciences Bratislava, Slovakia Max Planck Institute Department of Experimental Cardiology Bad Nauheim, GermanySearch for more papers by this authorJÁN SLEZÁK, JÁN SLEZÁK Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this author TANYA RAVINGEROVÁ, Corresponding Author TANYA RAVINGEROVÁ Institute for Heart Research Slovak Academy of Sciences Bratislava, Slovakiab Address for correspondence: Dr. T. Ravingerová, Institute for Heart Research, Slovak Academy of Sciences, Dubravska cesta 9, 842 33 Bratislava, Slovakia. Fax: 427 376 637.Search for more papers by this authorMIROSLAV BARANČÍK, MIROSLAV BARANČÍK Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorDEZIDER PANCZA, DEZIDER PANCZA Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorJÁN STYK, JÁN STYK Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorATTILA ZIEGELHÖFFER, ATTILA ZIEGELHÖFFER Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this authorWOLFGANG SCHAPER, WOLFGANG SCHAPER Institute for Heart Research Slovak Academy of Sciences Bratislava, Slovakia Max Planck Institute Department of Experimental Cardiology Bad Nauheim, GermanySearch for more papers by this authorJÁN SLEZÁK, JÁN SLEZÁK Institute for Heart Research Slovak Academy of Sciences Bratislava, SlovakiaSearch for more papers by this author First published: September 1996 https://doi.org/10.1111/j.1749-6632.1996.tb33503.xCitations: 2 a This study was supported, in part, by the EC COST Grant “Endogenous Cardioprotection” (CIPA CT 92 4009) and by Slovak Grant Agency for Science Grants Nos. 2/1257/95 and 2/1258/95. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Das, D. K. 1993. Ischaemic preconditioning and myocardial adaptation to ischaemia. Cardiovasc. Res.. 27: 2077– 2079. 2 Murry, C. E., R. B. Jennings & K. A. Reimer. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74: 1124– 1136. 3 Asimakis, G. K., K. Inners-McBride & V. R. Conti. 1993. Attenuation of postischaemic dysfunction by ischaemic preconditioning is not mediated by adenosine in the isolated rat heart. Cardiovasc. Res.. 27: 1522– 1530. 4 Liu, G. S., J. Thornton, D. M. Van Winkle, A. W. H. Stanley, R. A. Olsson & J. M. Downey. 1991. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350– 356. 5 Vegh, A., S. Komori, L. Szekeres & J. R. Parratt. 1992. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc. Res.. 26: 487– 495. 6 Parratt, J. R. 1993. Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc. Res.. 27: 693– 702. 7 Curtis, M. J., M. K. Pugsley & M. J. A. Walker. 1993. Endogenous chemical mediators of arrhythmogenesis in ischaemic heart disease. Cardiovasc. Res.. 27: 703– 719. 8 Vogt, A., M. Barancik, D. Weihrauch, M. Arras, T. Podzuweit & W. Schaper. 1994. Protection of ischemic porcine myocardium from infarction by an A1-receptor agonist is not mediated by protein kinase C. Circulation. 90: I– 371. 9 Vegh, A., J. Gy. Papp & J. R. Parratt. 1995. Pronounced antiarrhythmic effects of preconditioning in anaesthetised dogs: Is adenosine involved J. Mol. Cell. Cardiol.. 27: 349– 356. 10 Banerjee, A., C. Locke-Winter, K. B. Rogers et al. 1993. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an α1-adrenergic mechanism. Circ. Res.. 73: 656– 670. 11 Asimakis, G. K., K. Inners-McBride, V. R. Conti et al. 1994. Transient β adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction. Cardiovasc. Res.. 28: 1726– 1734. 12 Bankwala, Z., S. L. Hale & R. A. Kloner. 1994. α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation. 90: 1023– 1028. 13 Hu, K. & S. Nattel. 1994. Signal transduction systems underlying ischemic preconditioning in rat hearts. Circulation. 90: I– 108. 14 Bogoyevitch, M. A., P. J. Parker & P. H. Sugden. 1993. Characterization of protein kinase C isotype expression in adult rat heart. Circ. Res.. 72: 757– 767. 15 Tsuchida, A., Y. Liu, G. S. Liu et al. 1994. Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ. Res.. 75: 76– 85. 16 Ytrehus, K., Y. Liu & J. M. Downey. 1994. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol.. 266 (Heart Circ. Physiol. 35): H1145– H1152. 17 Speechly-Dick, M. E., M. M. Mocanu & D. M. Yellon. 1994. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ. Res.. 75: 586– 590. 18 Schott, R. J., S. Rohman, E. R. Brown & W. Schaper. 1990. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res.. 66: 1133– 1142. 19 Wilde, A. A. M., R. J. G. Peters & M. J. Janse. 1988. Catecholamine release and potassium accumulation in the isolated globally ischemic rabbit heart. J. Mol. Cell. Cardiol.. 20: 887– 896. 20 Haag, M., W. Gevers & R. G. Böhmer. 1985. The interaction between calcium and the activation of Na+, K+-ATPase by noradrenaline. Mol. Cell. Biochem. 66: 111– 116. 21 Walker, M. J. A., M. J. Curtis, D. J. Hearse et al. 1988. The Lambeth conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc. Res.. 22: 447– 455. 22 Vrbjar, N., J. Soos & A. Ziegelhoffer. 1984. Secondary structure of heart sarcolemmal proteins during interaction with metallic cofactors of (Na,K) ATPase. Gen. Physiol. Biophys.. 3: 317– 325. 23 Lowry, O. H., N. J. Rosebrough, A. L. Farr & R. J. Randall. 1953. Protein measurement with the folin phenol reagent. J. Biol. Chem.. 193: 265– 275. 24 Tausski, H. H. & E. E. Shorr. 1953. A microcolorimetric method for determination of inorganic phosphorus. J. Biol. Chem.. 202: 575– 585. 25 Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem.. 72: 248– 254. 26 Ravingerova, T., N. Tribulova, A. Ziegelhoeffer, J. Styk & L. Szekeres. 1993. Suppression of reperfusion induced arrhythmias in the isolated rat heart: pretreatment with 7-oxo prostacyclin in vivo. Cardiovasc. Res. 27: 1051– 1055. 27 Schömig, A., S. Fischer, T. Kurz et al. 1987. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ. Res.. 60: 194– 205. 28 Janse, M. J. 1992. The premature beat. Cardiovasc. Res.. 26: 89– 100. 29 Penny, W. J. 1984. The deleterious effects of myocardial catecholamines on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Eur. Heart J.. 5: 960– 973. 30 Jiang, J. P. & S. E. Downing. 1990. Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J. Biol. Med.. 63: 581– 591. 31 Wendt, D. J. & J. B. Martins. 1990. Autonomic neural regulation of intact Purkinje system of dogs. Am. J. Physiol. 258 (Heart Circ. Physiol.. 27): H1420– H1426. 32 Li, H. G., D. L. Jones, R. Yee et al. 1993. Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs. Am. J. Physiol. 265 (Heart Circ. Physiol.. 34): H1654– H1662. 33 Curtis, M. J., J. H. Botting, D. J. Hearse et al. 1989. The sympathetic nervous system, catecholamines and ischemia-induced arrhythmias: dependence upon serum potassium concentration. In Adrenergic System and Ventricular Arrhythmias in Myocardial Infarction. J. Brachman & A. Schömig, Eds. 205– 219. Springer-Verlag, Berlin . 34 Parratt, J. R., C. Campbell & O. Fagbemi. 1981. Catecholamines and early post-infarction arrhythmias: the effects of α-and β-adrenoceptor blockade. In Catecholamines and the Heart. W. Delius, E. Gerlach, H. Grobecker & W. Kübler, Eds. 269– 284. Springer-Verlag. Berlin . 35 Vegh, A., J. Gy. Papp & J. R. Parratt. 1994. Intracoronary noradrenaline suppresses ischaemia-induced ventricular arrhythmias in anaesthetized dogs. J. Mol. Cell. Cardiol.. 26: LXXXVII. 36 Ravingerova, T., W. Song, A. Ziegelhoeffer & J. Parratt. 1995. Delayed antiarrhythmic effect of pretreatment with norepinephrine in rats: the role of Na/K ATPase. J. Mol. Cell. Cardiol.. 27(6): A162. 37 Szekeres, L., J. Pataricza, Z. Szilvassy, E. Udvary & A. Vegh. 1992. Cardioprotection: endogenous protective mechanisms promoted by prostacyclin. Basic Res. Cardiol.. 87: 215– 221. 38 Yellon, D. M. & G. F. Baxter. 1995. “Second window of protection” or delayed preconditioning phenomenon: future horizons for myocardial protection J. Mol. Cell. Cardiol.. 27: 1023– 1034. 39 Clausen, T. 1983. Adrenergic control of Na+-K+-homeostasis. Acta Med. Scand. Suppl. 672: 111– 115. 40 Curtis, M. J. & D. J. Hearse. 1989. Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J. Mol. Cell. Cardiol.. 21: 21– 40. 41 Tosaki, A., N. S. Behjet, D. T. Engelman, R. M. Engelman & D. K. Das. 1995. Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J. Pharmacol. Exp. Ther.. 273: 689– 694. 42 Richard, G., R. Blessing & A. Schömig. 1994. Cardiac noradrenaline release accelerates adenosine formation in the ischemic rat heart: role of neuronal noradrenaline carrier and adrenergic receptors. J. Mol. Cell. Cardiol.. 26: 1321– 1328. 43 Winter, C. B., M. B. Mitchell, C. R. Locke-Winter et al. 1992. Adenosine induced preconditioning is dependent upon α1 adrenoreceptor activation. Circulation. 86(Suppl. I): I– 25. 44 Kitakaze, M., M. Hori & T. Kamada. 1993. Role of adenosine and its interaction with α adrenoceptor activity in ischaemic and reperfusion injury of the myocardium. Cardiovasc. Res.. 27: 18– 27. 45 Barancik, M., A. Vogt & W. Schaper. Differential activation of protein kinase C isoforms and mitogen-activated protein kinases during ischemia. Protein kinase C activation is not involved in adenosine Al-receptor agonist-mediated protection of porcine myocardium against ischemia. Circ. Res. In press. 46 Vogt, A., M. Barancik, D. Weihrauch, M. Arrass, T. Podzuweit & W. Schaper. 1994. Activation of protein kinase C fails to protect ischemic porcine myocardium from infarction in vivo. J. Mol. Cell. Cardiol. 26(6): CXVIII. 47 Vogt, A., M. Barancik, D. Weihrauch, M. Arrass, T. Podzuweit & W. Schaper. 1994. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo. Circulation 90(2): I– 647. 48 Lasley, R. D., M. A. Noble, P. J. Konyn & R. M. Mentzer. 1995. The protein kinase C inhibitor bisindolylmaleimide reduces myocardial interstitial purine accumulation and infarct size in the rabbit. Circulation. 92(8): I– 136. Citing Literature Volume793, Issue1Myocardial Preservation, Preconditioning, and Cellular AdaptationSeptember 1996Pages 43-53 ReferencesRelatedInformation
Publication Year: 1996
Publication Date: 1996-09-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 5
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot